ArticleCancer science2017

Rho GDP-dissociation inhibitor α is a potential prognostic biomarker and controls telomere regulation in colorectal cancer.

Dandan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.